2018
DOI: 10.1021/jacs.8b05309
|View full text |Cite
|
Sign up to set email alerts
|

Direct Visualization of Single-Nucleotide Variation in mtDNA Using a CRISPR/Cas9-Mediated Proximity Ligation Assay

Abstract: The accumulation of mitochondrial DNA (mtDNA) mutations in cells is strongly related to aging-associated diseases. Imaging of single-nucleotide variation (SNV) in mtDNA is crucial for understanding the heteroplasmy of mtDNAs that harbor pathogenic changes. Herein, we designed a CRISPR/Cas9-mediated proximity ligation assay (CasPLA) for direct visualization of the ND4 and ND5 genes in the mtDNAs of single cells. Taking advantage of the high specificity of CRISPR/Cas9, CasPLA can be used to image SNV in the ND4 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
94
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 107 publications
(94 citation statements)
references
References 52 publications
(77 reference statements)
0
94
0
Order By: Relevance
“…This unique conformational rearrangement may provide an ideal targeting site for various isothermal amplification techniques with enhanced robustness, specificity, and sensitivity due to the intrinsic properties of CRISPR effectors. For example, when combined with the exponential amplification reaction (EXPAR) and rolling cycle amplification (RCA), the CRISPR effector, Cas9, has been successfully applied in the efficient pre-screening of sgRNAs 27 and sensitive in situ genomic loci detection 28 , respectively. Thus, this CRISPR effectors-triggered strategy has great potentials to be applied in different situations.…”
Section: Introductionmentioning
confidence: 99%
“…This unique conformational rearrangement may provide an ideal targeting site for various isothermal amplification techniques with enhanced robustness, specificity, and sensitivity due to the intrinsic properties of CRISPR effectors. For example, when combined with the exponential amplification reaction (EXPAR) and rolling cycle amplification (RCA), the CRISPR effector, Cas9, has been successfully applied in the efficient pre-screening of sgRNAs 27 and sensitive in situ genomic loci detection 28 , respectively. Thus, this CRISPR effectors-triggered strategy has great potentials to be applied in different situations.…”
Section: Introductionmentioning
confidence: 99%
“…In this technique, Cas9/gRNA is directed to a specific sequence on mtDNA and local amplification of a fluorescence signal is achieved via a proximity ligation assay. This can enable visualization of individual nucleoids containing the specific mtDNA sequence of interest (63). The low copy number of mtDNAs in nucleoids (25) confirms that CasPLA can achieve high sensitivities at the level of single molecules.…”
Section: Labelling Specific Mtdna Variants In Cellsmentioning
confidence: 89%
“…Labelling of mtDNA containing single-nucleotide variations has also been achieved in situ using a technique termed CasPLA (63). In this technique, Cas9/gRNA is directed to a specific sequence on mtDNA and local amplification of a fluorescence signal is achieved via a proximity ligation assay.…”
Section: Labelling Specific Mtdna Variants In Cellsmentioning
confidence: 99%
“…For example, some newly developed CRISPR systems (such as Cas12a and Cas13a) have now be used for genotypic and phenotypic analysis of bacterial pathogens. 47,[65][66][67][68][69][70] Specically, a CRISPR-Cas13a/C2c2-based SHERLOCK platform has been applied for ultrafast and sensitive RNA/DNA quantitation, which is suitable for rapid identication of bacterial pathogens by detection of specic bacterial genes. 66 Recently, an allosteric probe-initiated catalysis and CRISPR-Cas13a amplication reaction (termed 'APC-Cas') was developed for detecting very low numbers of a bacterial pathogens without isolation 71 and can selectively quantify bacterial cells with a concentration from 1 to 10 5 CFU mL À1 in various types of samples, and the cost of reagents can be reduced to below $1 per test.…”
Section: Discussionmentioning
confidence: 99%